Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2

Status

Completed 5Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1B-cell Tumors 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × efavirenz × Clear all
NCT05076682 2025-12-03

Renaissance

Fudan University

Phase 2 Recruiting
80 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00964171 2025-08-28

PANTER

Institut Bergonié

Phase 2 Completed
19 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05560360 2023-02-02

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
20 enrolled
Lymphoid

B-cell Tumors

NCT00964002 2022-05-16

FAVE

Institut Bergonié

Phase 2 Completed
61 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed
25 enrolled 11 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00799136 2013-09-12

CATCH

Ontario Clinical Oncology Group (OCOG)

Phase 2 Completed
6 enrolled
LymphoidSarcoma

HIV Infections, Lymphoma, AIDS-Related, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡